Evaxion A/S (EVAX)
Uses AI to design personalized cancer and infection vaccines.
$2.80-0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+7.3%
The outlook
EVAX trades near the lower end of its 52-week range and sits below both short- and long-term moving averages. Analyst coverage leans bullish with an average price target suggesting significant upside, though the stock's weak near-term trend and low overall sentiment score suggest caution. The data shows a disconnect between analyst targets and current price momentum.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Price targetAvg target +302% vs current price
Analyst price target
~12-month · 4 analysts$11.25average target+301.8% vs now
Now $2.80
Low $9.00High $16.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$23.4M
52-wk high
$12.15
52-wk low
$2.45
50-day avg
$3.48
200-day avg
$4.40
Trailing P/E
—